We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site

Watch a 1-hour webinar from the 2018 Antibody Engineering & Therapeutics Digital Week titled, “Emerging Technologies for Finding Rare Antibodies,” featuring scientists from Berkeley Lights and Teva Pharmaceuticals.

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Antibody Discovery Beacon System

DATASHEET: Opto® Memory B Discovery Rabbit Workflow

Rapid workflow to screen rabbit memory B cells to discover high-value monoclonal antibodies
Robust activation of rabbit memory B cells using proprietary feeder-free activation media
Efficient recovery of antigen-specific antibody sequences for downstream characterization and development

Antibody Discovery

Webinar: Looking to the Future: What’s next in Antibody Therapeutics

At the 2021 AE&T EU conference, Tracey Mullens, CEO of Abveris, and Brian Walters, CEO of Genovac, joined John Proctor, SVP Antibody Therapeutics, for a discussion about the evolving landscape of antibody therapeutics, the technologies they have turned to address today’s complex targets, and how they are preparing for tomorrow’s challenges.

Antibody Discovery

Webinar: Accelerating Antibody Discovery in the Modern Therapeutic Landscape

Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.